Maj J, Bijak M, Dziedzicka-Wasylewska M, Rogoz R, Rogóz Z, Skuza G, Tokarski T
Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Psychopharmacology (Berl). 1996 Sep;127(1):73-82. doi: 10.1007/BF02805977.
Effects of paroxetine (10 mg/kg PO, twice daily, 14 days) on 5-HT receptor subpopulations in the brain were evaluated pharmacologically, electrophysiologically and biochemically in male Wistar rats. Imipramine was used for comparison. Repeated paroxetine antagonized the 8-OH-DPAT-induced behavioural syndrome (a 5-HT1A effect); imipramine showed similar, yet weaker, activity. The 5-HT-or 8-OH-DPAT-induced inhibition of population spikes in hippocampal slices was increased by both those repeated antidepressants. Repeated (or acute) paroxetine decreased the density of and increased the affinity for 5-HT1A receptors ([3H]-8-OH-DPAT used as ligand) in the hippocampus, while imipramine induced opposite effects. m-Chlorophenyl piperazine (m-CPP)-evoked exploratory hypoactivity, a 5-HT2C effect, was reduced by repeated paroxetine, but not by imipramine. Either of the antidepressants given repeatedly antagonized TFMPP-induced hyperthermia (another putative 5-HT2C effect). 5-HTP-induced head twitches (a 5-HT2A effect) were inhibited by repeated paroxetine or imipramine. Either antidepressant given repeatedly decreased the density of 5-HT2A receptors ([3H]-ketanserin as a ligand) in the brain cortex, but did not change their affinity. The present results indicate that paroxetine given repeatedly induces secondary changes in 5-HT2 receptors, which lead to reduction of the 5-HT2 neurotransmission (reduced responsiveness of 5-HT2 postsynaptic receptors). The consequences of the secondary changes in 5-HT1A receptors, found here still await clarification.
在雄性Wistar大鼠中,通过药理学、电生理学和生物化学方法评估了帕罗西汀(10mg/kg口服,每日两次,共14天)对大脑中5-羟色胺(5-HT)受体亚群的影响。以丙咪嗪作为对照。重复给予帕罗西汀可拮抗8-羟基二丙胺基四氢吡啶(8-OH-DPAT)诱导的行为综合征(一种5-HT1A效应);丙咪嗪表现出相似但较弱的活性。这两种重复给药的抗抑郁药均可增强5-HT或8-OH-DPAT诱导的海马切片群体峰电位抑制。重复(或急性)给予帕罗西汀可降低海马中5-HT1A受体的密度并增加其亲和力(以[3H]-8-OH-DPAT作为配体),而丙咪嗪则产生相反的作用。重复给予帕罗西汀可减轻间氯苯哌嗪(m-CPP)诱发的探索性活动减退,这是一种5-HT2C效应,而丙咪嗪则无此作用。重复给予任何一种抗抑郁药均可拮抗三氟甲基苯基哌嗪(TFMPP)诱导的体温过高(另一种假定的5-HT2C效应)。重复给予帕罗西汀或丙咪嗪均可抑制5-羟色胺酸(5-HTP)诱导的头部抽搐(一种5-HT2A效应)。重复给予任何一种抗抑郁药均可降低大脑皮层中5-HT2A受体的密度(以[3H]-酮舍林作为配体),但不改变其亲和力。目前的结果表明,重复给予帕罗西汀可诱导5-HT2受体发生继发性变化,从而导致5-HT2神经传递减少(5-HT2突触后受体反应性降低)。此处发现的5-HT1A受体继发性变化的后果仍有待阐明。